X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (18) 18
female (15) 15
breast cancer (14) 14
cancer (9) 9
middle aged (9) 9
breast neoplasms - surgery (8) 8
mastectomy (8) 8
oncology (8) 8
breast neoplasms - drug therapy (7) 7
index medicus (7) 7
surgery (6) 6
breast neoplasms - radiotherapy (5) 5
clinical trials (5) 5
lumpectomy (5) 5
mastectomy, segmental (5) 5
medicine, general & internal (5) 5
radiation (5) 5
surgical adjuvant breast (5) 5
therapy (5) 5
chemotherapy (4) 4
medical colleges (4) 4
womens health (4) 4
aged (3) 3
antineoplastic agents, hormonal - therapeutic use (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
article (3) 3
breast (3) 3
breast neoplasms - pathology (3) 3
breast neoplasms - therapy (3) 3
combined modality therapy (3) 3
health care (3) 3
health maintenance organizations (3) 3
product development (3) 3
quality of life (3) 3
radiation-therapy (3) 3
radiotherapy (3) 3
tamoxifen (3) 3
tamoxifen - therapeutic use (3) 3
treatment outcome (3) 3
trial (3) 3
tumors (3) 3
women (3) 3
abridged index medicus (2) 2
adjuvant treatment (2) 2
adult (2) 2
angiogenesis (2) 2
anthracyclines (2) 2
antineoplastic agents, hormonal - administration & dosage (2) 2
antineoplastic agents, hormonal - adverse effects (2) 2
aromatase inhibitors - administration & dosage (2) 2
aromatase inhibitors - therapeutic use (2) 2
biometry (2) 2
breast - pathology (2) 2
breast neoplasms - psychology (2) 2
canada (2) 2
cancer surgery (2) 2
carcinoma (2) 2
carcinoma, ductal, breast - drug therapy (2) 2
carcinoma, ductal, breast - radiotherapy (2) 2
carcinoma, ductal, breast - surgery (2) 2
care and treatment (2) 2
chemotherapy, adjuvant (2) 2
comparing total mastectomy (2) 2
conferences, meetings and seminars (2) 2
cyclophosphamide (2) 2
depression (2) 2
disease-free survival (2) 2
docetaxel (2) 2
double-blind method (2) 2
doxorubicin - administration & dosage (2) 2
drug administration schedule (2) 2
follow-up studies (2) 2
hematology, oncology and palliative medicine (2) 2
internal medicine (2) 2
italy (2) 2
mastectomy - methods (2) 2
mastectomy - psychology (2) 2
neoadjuvant therapy (2) 2
neoplasm invasiveness (2) 2
neoplasm recurrence, local - epidemiology (2) 2
neoplasm recurrence, local - psychology (2) 2
nitriles - administration & dosage (2) 2
nitriles - therapeutic use (2) 2
patient selection (2) 2
pharmacology & pharmacy (2) 2
postmenopausal women (2) 2
postmenopause (2) 2
preoperative chemotherapy (2) 2
quality-of-life (2) 2
radiation therapy (2) 2
relapse (2) 2
standards (2) 2
survival (2) 2
survival analysis (2) 2
symptoms (2) 2
tamoxifen - administration & dosage (2) 2
tamoxifen - adverse effects (2) 2
taxoids - administration & dosage (2) 2
time factors (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 12, pp. 1183 - 1192
Summary Background We studied the effect on tumour response to neoadjuvant therapy of the substitution of lapatinib for trastuzumab in combination with weekly... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | WOMEN | CELLS | SURGICAL ADJUVANT BREAST | PREOPERATIVE CHEMOTHERAPY | ONCOLOGY | GW572016 | CHEMOTHERAPY PLUS TRASTUZUMAB | PERTUZUMAB | INHIBITOR | DOCETAXEL | Breast Neoplasms - surgery | Cyclophosphamide - administration & dosage | Puerto Rico | United States | Humans | Receptor, ErbB-2 - metabolism | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Protein Kinase Inhibitors - adverse effects | Molecular Targeted Therapy | Breast Neoplasms - enzymology | Antibodies, Monoclonal, Humanized - administration & dosage | Time Factors | Biomarkers, Tumor - metabolism | Mastectomy | Female | Neoadjuvant Therapy | Quinazolines - administration & dosage | Receptor, ErbB-2 - antagonists & inhibitors | Chemotherapy, Adjuvant | Biomarkers, Tumor - antagonists & inhibitors | Odds Ratio | Paclitaxel - administration & dosage | Doxorubicin - administration & dosage | Drug Administration Schedule | Logistic Models | Treatment Outcome | Chi-Square Distribution | Breast Neoplasms - drug therapy | Canada | Protein Kinase Inhibitors - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Intention to Treat Analysis | Quinazolines - adverse effects | Trastuzumab | Health maintenance organizations | Neoadjuvant therapy | Medical colleges | Care and treatment | Cyclophosphamide | Anthracyclines | Adjuvant treatment | Breast cancer | Product development | Public health | Cancer | Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 9, pp. 1037 - 1048
Journal Article
CANCER, ISSN 0008-543X, 04/1992, Volume 69, Issue 8, pp. 2111 - 2115
Journal Article
Cancer, ISSN 0008-543X, 09/1987, Volume 60, Issue 6, p. 1415
To improve our understanding of physician reluctance to participate in randomized clinical trials, we examined physician responses to the regulation of... 
Humans | Therapeutic Human Experimentation | Physician-Patient Relations | Clinical Trials as Topic | Random Allocation | Disclosure | Role | Informed Consent | Social Responsibility | Internationality | Consent Forms | Government Regulation | Researcher-Subject Relations | Physician's Role
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10021, pp. 849 - 856
Summary Background Ductal carcinoma in situ is currently managed with excision, radiotherapy, and adjuvant hormone therapy, usually tamoxifen. We postulated... 
Internal Medicine | INTRADUCTAL BREAST-CANCER | MEDICINE, GENERAL & INTERNAL | SURGICAL ADJUVANT BREAST | RADIATION-THERAPY | B-17 | Breast Neoplasms - surgery | Triazoles - administration & dosage | Triazoles - adverse effects | Thrombosis - chemically induced | Age Factors | Humans | Middle Aged | Tamoxifen - administration & dosage | Nitriles - administration & dosage | Antineoplastic Agents, Hormonal - adverse effects | Aromatase Inhibitors - adverse effects | Carcinoma, Ductal, Breast - drug therapy | Mastectomy, Segmental | Antineoplastic Agents, Hormonal - therapeutic use | Postmenopause | Female | Embolism - chemically induced | Aromatase Inhibitors - therapeutic use | Triazoles - therapeutic use | Aromatase Inhibitors - administration & dosage | Carcinoma, Ductal, Breast - surgery | Double-Blind Method | Administration, Oral | Antineoplastic Agents, Hormonal - administration & dosage | Combined Modality Therapy | Breast Neoplasms - drug therapy | Breast Neoplasms - radiotherapy | Carcinoma, Ductal, Breast - radiotherapy | Tamoxifen - therapeutic use | Tamoxifen - adverse effects | Nitriles - adverse effects | Nitriles - therapeutic use | Lumpectomy | Medical colleges | Carcinoma | Radiation | Clinical trials | Postmenopausal women | Hormones | Tamoxifen | Radiotherapy | Biometry | Health maintenance organizations | Product development | Cancer | Chemotherapy | Womens health | Older people | Breast cancer | Radiation therapy | Cancer surgery
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10021, pp. 857 - 865
Journal Article
The Canadian Journal of Infectious Diseases & Medical Microbiology, ISSN 1712-9532, 2015, Volume 26, Issue Suppl B, pp. 4B - 5B
Journal Article
CANADIAN MEDICAL ASSOCIATION JOURNAL, ISSN 0820-3946, 1998, Volume 158, Issue 3, pp. S15 - S21
Objective: To assist women and their physicians in making the most clinically effective and personally acceptable decision regarding the choice of primary... 
EARLY LOCAL RECURRENCE | TUMOR-EXCISION | MEDICINE, GENERAL & INTERNAL | SURGICAL ADJUVANT BREAST | FOLLOW-UP | COMPARING TOTAL MASTECTOMY | SEGMENTAL-MASTECTOMY | EXTENSIVE INTRADUCTAL COMPONENT | CONSERVATIVE SURGERY | CONSERVING THERAPY | RADIATION-THERAPY | Health care | Mastectomy | Therapy | Breast cancer | Standards | Cancer
Journal Article